This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Information sources re: prescribing in pregnancy

Authoring team

In the British National Formulary (BNF), Appendix 4 presents risk-benefit information about drugs and indicates the stage of pregnancy at which a particular drug is most likely to harm the fetus.

Other information sources include specialist reference books (2) or via contacting the drug manufacturer. "Data sheets are not very helpful when prescribing in pregnancy as they are often written from a medicolegal standpoint and so tend to advise against the use of a drug in pregnancy (3)".

Reference

  1. BNF Appendix 4
  2. Briggs GG et al. Drugs in pregnancy and lactation. Baltimore: Williams and Wilkins
  3. Drug and Therapeutics Bulletin (1996). Pre-conception, pregnancy and prescribing, 34 (4), 25-27.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.